Please use this identifier to cite or link to this item:
|Title:||The importance of the experiences of initial diagnosis and treatment failure when switching antiepileptic drugs.|
|Authors:||Thomas, Rhys H;Mullins, Jane M;Hammond, Carrie L;Smith, Philip E M;Kerr, Mike P|
|Affiliation:||Alan Richens Unit, Wales Epilepsy Centre, University Hospital of Wales, Cardiff CF14 4XW, UK; Wales Epilepsy Research Network (WERN), College of Medicine, Swansea University, SA2 8PP, UK; Epilepsy Research Centre, University of Melbourne, Austin Health, Heidelberg 3084, Australia. Electronic address: Rhys.Thomas@Swansea.ac.uk.|
|Citation:||Epilepsy & Behavior : E&b 2013; 29(3): 492-6|
|Abstract:||We sought to understand the issues that lead from the need to change antiepileptic drugs (AEDs) and how this may influence someone's feelings regarding swapping to another drug. We conducted semistructured interviews with 14 people with epilepsy, four months after changing from AED monotherapy. Interviews were digitally recorded, transcripts were coded independently, and thematic analysis was undertaken through group work. There were seven major themes: failure, the reason behind the failure, and the experience itself; expectations; previous experience; personality and life events; side effects; impact of diagnosis; and outcome. Clinical outcome and patients' ideas of outcome were often discordant. Each drug change arises from a position of failure that elicits strong feelings of loss of control and vulnerability in participants. Recognizing the need for counseling of targeted individuals undergoing AED change is key. Unresolved emotional issues surrounding biographical disruption following diagnosis were potent modifiers of the change process.|
|Internal ID Number:||24094841|
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.